CLINICAL PRACTICE GUIDELINES AGA Clinical Practice Guidelines on the Role of Probiotics in the Management of Gastrointestinal Disorders Grace L. Su, et al. INTRODUCTION This document presents the official recommendations of the American Gastroenterological Association (AGA) on the role of probiotics in the management of gastrointestinal disorders. The guideline was developed by the AGA Institute’s…
Dietary Interventions and Irritable Bowel Syndrome – What Really Works? Teodora Surdea-Blaga; Anamaria Cozma-Petrut; Dan Lucian Abstract Purpose of Review: The review examines the latest research on the use of dietary interventions in the management of irritable bowel syndrome (IBS) in order to understand what is the evidence supporting the efficacy of a dietary approach in…
New videos show RNA as it’s never been seen First-ever data-driven videos illuminate RNA’s mysterious folding process leggi tutto
The Use of Rifaximin in the Prevention of Overt Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt. A Randomized Controlled Trial Christophe Bureau, MD, PhD et al Background: The efficacy of rifaximin in the secondary prevention of overt hepatic encephalopathy (HE) is well documented, but its effectiveness in preventing a first episode in patients after transjugular…
Shunt-Induced Hepatic Encephalopathy in TIPS: Current Approaches and Clinical Challenges by Philipp Schindler et al. Transjugular intrahepatic portosystemic shunt (TIPS) is an established treatment tool in decompensated liver cirrhosis that has been shown to prolong transplant-free survival. Hepatic encephalopathy (HE) is a frequent complication of decompensated cirrhosis, eventually induced and/or aggravated by TIPS, that remains…
Infezione da Clostridium difficile e malattie infiammatorie croniche intestinali LUCIO CAPURSO1, MAURIZIO KOCH2 1Primario Emerito Gastroenterologia, Ospedale San Filippo Neri, Roma; 2Senior Director, Unità Complessa di Gastroenterologia ed Epatologia, Ospedale San Filippo Neri, Roma. Pervenuto su invito il 19 ottobre 2020. Riassunto. Pazienti affetti da malattie infiammatorie croniche intestinali (MICI) hanno un rischio aumentato di sviluppare un’infezione da Clostridium difficile (CD)…